# Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study

> **NCT02325492** · PHASE2 · TERMINATED · sponsor: **Galmed Pharmaceuticals Ltd** · enrollment: 10 (actual)

## Conditions studied

- Gallstones

## Interventions

- **DRUG:** Aramchol
- **DRUG:** Placebo
- **DEVICE:** Ultrasound

## Key facts

- **NCT ID:** NCT02325492
- **Lead sponsor:** Galmed Pharmaceuticals Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Protocol redesign
- **Last updated:** 2015-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02325492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02325492, "Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02325492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*